Patents by Inventor Paul-Andre Finot
Paul-Andre Finot has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8383680Abstract: A method is provided for the prevention and treatment of patients having impaired gastro-intestinal tract function. The method comprises the steps of administering to a patient requiring same free amino acids including about 9.0% to about 17.0% glutamic acid.Type: GrantFiled: October 18, 2011Date of Patent: February 26, 2013Assignee: Nestec S.A.Inventors: Constance Whippie, Olivier Ballevre, Julio Boza, Paul-Andre Finot
-
Patent number: 8178487Abstract: A method of providing glutamine to a patient. A nutritional composition which includes whey protein, or a protein mixture which simulates the amino acid profile of whey protein, as a protein source is enterally administered to the patient. The whey protein may be a hydrolyzed whey protein. The patient may be a stressed patient, pre-term baby, or athlete.Type: GrantFiled: November 24, 2008Date of Patent: May 15, 2012Assignee: Nestec S.A.Inventors: Julio Boza, Olivier Ballevre, Paul-Andre Finot
-
Publication number: 20120035234Abstract: A composition is described that can be used in prevention or treatment of patients having impaired gastro-intestinal tract function. The composition comprises free amino acids including about 9.0% to about 17.0% glutamic acid. Methods of treatment of impaired gastro-intestinal tract function are described.Type: ApplicationFiled: October 18, 2011Publication date: February 9, 2012Applicant: Nestec S.A.Inventors: Constance Whippie, Olivier Ballevre, Julio Boza, Paul-André Finot
-
Patent number: 8067471Abstract: A composition is described that can be used in prevention or treatment of patients having impaired gastro-intestinal tract function. The composition comprises free amino acids including about 9.0% to about 17.0% glutamic acid. Methods of treatment of impaired gastro-intestinal tract function are described.Type: GrantFiled: April 28, 2006Date of Patent: November 29, 2011Assignee: Nestec S.A.Inventors: Constance Whippie, Olivier Ballevre, Julio Boza, Paul-André Finot
-
Patent number: 7794744Abstract: The present invention relates to a method for preparing an enteral nutrition at the bed of a patient, which involves the use of a standard enteral solution to which is added, via a closed system, one or more compositions in module form, containing selected nutrients, adapted for a specific clinical condition. The present invention also pertains to the different modules, that are preferably in dry form and to the use thereof in the treatment and/or nourishment of a critically ill person.Type: GrantFiled: April 3, 2001Date of Patent: September 14, 2010Assignee: Nestec S.A.Inventors: Olivier Ballevre, Julio Boza, Denis Breuille, Paul-André Finot, Véronique Jaussan, Claudia Roessle, Thomas Schweizer
-
Patent number: 7691906Abstract: A composition for use as a medicament, functional food or nutritional product is described which comprises at least one lipid wherein the lipid provides greater than 35% total energy of the composition. A preferred embodiment comprises a n-6/n-3 fatty acid ratio of about 2/1 to 7/1. In addition, a method of preparing the composition; use of the composition in the manufacture of a medicament, functional food or nutritional product; and a method of treatment or treatment or prevention of sepsis or inflammatory shock which comprises administering an effective amount of the composition are described.Type: GrantFiled: August 16, 2005Date of Patent: April 6, 2010Assignees: Nestec S.A., Institut de la Research AgronomiqueInventors: Marco Turini, Claudia Roessle, Denis Breuille, Gayle Crozier-Willi, Paul André Finot, Myriam Richelle, Guy Dutot, Christiane Obled
-
Publication number: 20090075862Abstract: A method of providing glutamine to a patient. A nutritional composition which includes whey protein, or a protein mixture which simulates the amino acid profile of whey protein, as a protein source is enterally administered to the patient. The whey protein may be a hydrolyzed whey protein. The patient may be a stressed patient, pre-term baby, or athlete.Type: ApplicationFiled: November 24, 2008Publication date: March 19, 2009Applicant: NESTEC S.A.Inventors: Julio Boza, Olivier Ballevre, Paul-Andre Finot
-
Publication number: 20060247312Abstract: A composition is described that can be used in prevention or treatment of patients having impaired gastro-intestinal tract function. The composition comprises free amino acids including about 9.0% to about 17.0% glutamic acid. A method of production of the composition; use of the composition in the manufacture of a medicament; and a method of treatment of impaired gastro-intestinal tract function are described.Type: ApplicationFiled: April 28, 2006Publication date: November 2, 2006Applicant: NESTEC S.A.Inventors: Constance Whippie, Olivier Ballevre, Julio Boza, Paul-Andre Finot
-
Patent number: 6995189Abstract: A composition for use as a medicament or nutritional product is described which comprises at least one lipid wherein the lipid provides greater tan 35% total energy of the composition. A prefered embodiment comprises a n-6/n-3 fatty acid ratio of about 2/1 to 7/1. In addition, a method of preparing the composition; use of the composition in the manufacture of a medicament or nutritional product; and a method of treatment or prevention of sepsis or inflammatory shock which comprises administering an effective amount of the composition are described.Type: GrantFiled: September 7, 2000Date of Patent: February 7, 2006Assignee: Nestec S.A.Inventors: Marco Turini, Claudia Roessle, Denis Breuille, Gayle Crozier-Willi, Paul André Finot, Myriam Richelle, Guy Dutot
-
Publication number: 20050064014Abstract: The present invention relates to the use of cystathionine in a nutritional composition, a food supplement, a prophylactic composition or an infant formula.Type: ApplicationFiled: October 8, 2002Publication date: March 24, 2005Inventors: Paul-Andre Finot, Tuong Huynh-Ba, Jacques Vuichoud, Denis Breuille
-
Patent number: 6833350Abstract: Methods for maintaining, improving or increasing the synthesis of mucins by administering a nutritional composition or supplement that contains a therapeutically effective amount of threonine are provided. The present invention further provides methods for treating a variety of disease states characterized by alterations to the mucin levels, such as, intestinal inflammatory and bacterial infections or other like disease states.Type: GrantFiled: January 30, 2001Date of Patent: December 21, 2004Assignee: Nestec S.A.Inventors: Olivier Ballevre, Paul-Andre Finot, Denis Breuille
-
Publication number: 20040096478Abstract: A composition is described that can be used in prevention or treatment of patients having impaired gastro-intestinal tract function. The composition comprises free amino acids including about 9.0% to about 17.0% glutamic acid. A method of production of the composition; use of the composition in the manufacture of a medicament; and a method of treatment of impaired gastro-intestinal tract function are described.Type: ApplicationFiled: January 2, 2003Publication date: May 20, 2004Inventors: Constance Whippie, Olivier Ballevre, Julio Boza, Paul-Andre Finot
-
Patent number: 6733770Abstract: A nutritional enteral composition intended for favoring the growth and maturation of non-mature gastro-intestinal tracts of young mammals, which contains as a protein source a mixture of dietary protein hydrolysates and intact proteins being partly in the form of bioactive peptides.Type: GrantFiled: March 4, 2002Date of Patent: May 11, 2004Assignee: Nestec S.A.Inventors: Clara L. Garcia-Rodenas, Paul-Andre Finot, Jean-Claude Maire, Olivier Ballevre, Anne Net-Hughes, Ferdinand Haschke
-
Publication number: 20030161863Abstract: The present invention relates to a method for preparing an enteral nutrition at the bed of a patient, which involves the use of a standard enteral solution to which is added, via a closed system, one or more compositions in module form, containing selected nutrients, adapted for a specific clinical condition. The present invention also pertains to the different modules, that are preferably in dry form and to the use thereof in the treatment and/or nourishment of a critically ill person.Type: ApplicationFiled: February 21, 2003Publication date: August 28, 2003Inventors: Olivier Ballevre, Julio Boza, Denis Breuille, Paul-Andre Finot, Veronique Jaussan, Claudia Roessle, Thomas Schweizer
-
Publication number: 20030157186Abstract: Methods for maintaining, improving or increasing the synthesis of mucins by administering a nutritional composition or supplement that contains a therapeutically effective amount of threonine are provided. The present invention further provides methods for treating a variety of disease states characterized by alterations to the mucin levels, such as, intestinal inflammatory and bacteria infections or other like disease states.Type: ApplicationFiled: February 21, 2003Publication date: August 21, 2003Inventors: Olivier Ballevre, Paul-Andre Finot, Denis Breuille
-
Publication number: 20010031723Abstract: Methods for maintaining, improving or increasing the synthesis of mucins by administering a nutritional composition or supplement that contains a therapeutically effective amount of threonine are provided. The present invention further provides methods for treating a variety of disease states characterized by alterations to the mucin levels, such as, intestinal inflammatory and bacterial infections or other like disease states.Type: ApplicationFiled: January 30, 2001Publication date: October 18, 2001Inventors: Olivier Ballevre, Paul-Andre Finot, Denis Breuille
-
Patent number: 4052372Abstract: A process for the preparation of .epsilon.-(.gamma.-glutamyl)-lysine which comprises heating lysine glutamate for at least 5 hours at a temperature of at least 120.degree. C by means of an inert heat-carrier fluid, and isolating .epsilon.-(.gamma.-glutamyl)-lysine from the conversion product thus obtained.The inert heat-carrier fluid can be either a gas such as air or nitrogen, or a liquid such as n-amylalcohol, kerosene, nonane, 1,1,2,2-tetrachloroethane, 1-octanol or 2-ethyl-1-butanol.Type: GrantFiled: January 30, 1976Date of Patent: October 4, 1977Assignee: Societe d'Assistance Technique pour Produits Nestle S.A.Inventors: Paul-Andre Finot, Pierre Hirsbrunner, Raymond Bertholet
-
Patent number: 3993795Abstract: The present invention is concerned with a process for treating foodstuffs low in lysine, such as cereals, which comprises adding to the foodstuff an effective amount of at least one metabolic substitute for L-lysine. This substitute may be chosen in the group comprising the .epsilon.-aminoacyl-L-lysines, the .alpha., .epsilon.-diaminoacyl-L-lysines and the Schiff's bases of L-lysine.Type: GrantFiled: February 6, 1975Date of Patent: November 23, 1976Assignee: Societe d'Assistance Technique pour Produits Nestle S.A.Inventors: Jean Mauron, Paul-Andre Finot, Francoise Mottu